Twenty years ago, a visionary collaboration across Europe gave rise to ELISA-based assays that brought simplicity and standardization to diagnostic complement testing, enabling clinicians and researchers worldwide to assess the classical, alternative, and lectin pathways in a single, accessible format.
Today, the WIESLAB® assays have become a cornerstone in diagnostics and research, supporting studies in autoimmune diseases, infections, and therapeutic trials. Their standardized design ensures reproducibility and reliability across laboratories, making them indispensable for advancing complement-targeting therapies.
